Keros Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KROS and other ETFs, options, and stocks.

About KROS

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. 

CEO
Jasbir S. Seehra
CEOJasbir S. Seehra
Employees
60
Employees60
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2015
Founded2015
Employees
60
Employees60

KROS Key Statistics

Market cap
1.02B
Market cap1.02B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
168.97K
Average volume168.97K
High today
$39.58
High today$39.58
Low today
$37.96
Low today$37.96
Open price
$38.43
Open price$38.43
Volume
235.25K
Volume235.25K
52 Week high
$68.29
52 Week high$68.29
52 Week low
$24.38
52 Week low$24.38

KROS Earnings

-$1.13
-$0.75
-$0.38
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.